Access to, and uptake of, antiretroviral therapy in a developing country with high HIV prevalence: A population-based cohort study in rural Uganda, 2004-2008

Tropical Medicine and International Health

Volumn 17, Issue 8, 2012, Pages

  Kazooba, Patrick ^a   Kasamba, Ivan ^a   Baisley, Kathy ^b   Mayanja, Billy N ^a   Maher, Dermot ^a,b  

^a MRC   (Uganda)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Access and uptake; Antiretroviral therapy; Cohort study; Uganda

Indexed keywords

ADULT; AGE CLASS; ANTIMICROBIAL ACTIVITY; COHORT ANALYSIS; DEMOGRAPHY; DEVELOPING WORLD; DISEASE PREVALENCE; DISEASE TREATMENT; HEALTH SERVICES; HUMAN IMMUNODEFICIENCY VIRUS; PUBLIC ACCESS; PUBLIC HEALTH; RURAL AREA; SURVIVAL; TEMPORAL ANALYSIS;

ADULT; ARTICLE; DEVELOPING COUNTRY; FEMALE; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MAJOR CLINICAL STUDY; MALE; SURVIVAL; UGANDA;

ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RURAL POPULATION; SOCIOECONOMIC FACTORS; UGANDA; YOUNG ADULT;

UGANDA;

EID: 84864389194     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.02942.x     Document Type: Article

References (27)

1. Badri M, Cleary S, Maartens G et al. (2006) When to initiate HAART in sub-Saharan Africa? A South African cost-effectiveness study Antiviral Therapy 11, 63-72.
2. De Paoli MM, Manongi R & Klepp KI (2004) Factors influencing acceptability of voluntary counseling and HIV-testing among pregnant women in Northern Tanzania. AIDS Care 16, 411-425.
3. Government of Uganda (2010) UNGASS Country progress report. Uganda, January 2008-December 2009. (accessed 1 February 2010).
4. Jahn A, Floyd S, McGrath N et al. (2008) Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi. Lancet 371, 1603-1611.
5. Johnson LF & Boulle A (2011) How should access to antiretroviral treatment be measured? Bulletin of the World Health Organization 89, 157-160.
6. Loewenson R & McCoy D (2004) Access to antiretroviral therapy in Africa. BMJ 328, 241-242.
7. Mahy M, Tassie JM, Ghys PD et al. (2010) Estimation of antiretroviral therapy coverage: methodology and trends. Current opinion in HIV and AIDS 5, 97-102.
8. Mbulaiteye S, Mahe C, Whitworth J et al. (2002) Declining HIV-1 incidence and associated prevalence over 10years in a rural population in south-west Uganda: a cohort study. Lancet 360, 41-46.
9. Morgan D, Malamba SS, Maude GH et al. (1997) An HIV-1 natural history cohort and survival times in rural Uganda. AIDS 11, 633-640.
10. Mulder DW, Nunn AJ, Wagner HU, Kamali A & Kengeya-Kayondo JF (1994) HIV-1 incidence and HIV-1 associated mortality in a rural Ugandan population cohort. AIDS 8, 87-92.
11. Murray L, Semrau K, McCauley E (2009) Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care 21, 78-86.
12. Muula AS and Kataika E (2008) Assessment of equity in the uptake of anti-retrovirals in Malawi. Equinet discussion paper 58. available at website http://www.equinetafrica.org/bibl/docs/dis58finmuula.pdf.
13. Nakibinge S, Maher D, Katende J, Kamali A, Grosskurth H & Seeley J (2009) Community engagement in HIV research: two decades of experience from a research project on HIV in rural Uganda. Tropical Medicine and International Health 14, 190-195.
14. Nunn AJ, Biryahwaho B, Downing RG, van der Groen G, Ojwiya A & Mulder DW (1993) Algorithms for detecting antibodies to HIV results from a rural Ugandan Cohort. AIDS 7, 1057-1061.
15. Schneider M, Zwahlen M & Egger M (2004) Natural history and mortality in HIV-positive individuals living in resource-poor settings: a literature review. Commissioned by UNAIDS. (accessed 1 February 2011).
16. Shafer LA, Biraro S, Nakiyingi-Miiro J et al. (2008) HIV prevalence and incidence are no longer falling in southwest Uganda: evidence from a rural population cohort 1989-2005. AIDS 22, 1641-1649.
17. Uganda AIDS Commission (2007) National HIV & AIDS Strategic Plan (2007/8-2011/12) document/wcms_125553.pdf.
18. Uganda Ministry of Health (2003) National Antiretroviral Treatment and Care Guidelines for adults and children, 1st edition August 2003.
19. Uganda STD/AIDS Control programme (2002) Trends in HIV prevalence and sex behaviour 1990-2000 in Uganda.
20. UNAIDS/WHO (2009) AIDS Epidemic Update: December 2009. WHO, Geneva, (accessed 1 February 2011).
21. WHO/UNAIDS/UNICEF (2010) Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2010. Geneva, World Health Organization, (accessed 01 February 2011).
22. World Health Organization (2006) Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach (2006 revision) (accessed 1 February 2011).
23. World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach (2010 version) (accessed 1 February 2011).
24. Wringe A, Floyd S, Kazooba P et al. (2012) Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa. Tropical Medicine and International Health 17, e38-e48.
25. Zaba B, Kasamba I, Floyd S et al. (2012) Mortality and attrition among patients in the Tanzanian National HIV Care and Treatment Programme. Tropical Medicine and International Health 17, e3-e14.
26. Zachariah R, Harries AD, Manzi M et al. (2006) Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport. PLoS ONE 1, e121.
27. Zwahlen M for the eligibility for ART in lower income countries (eART-linc) collaboration (2008). Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies. Sexually transmitted infections 84, i31-i36.